Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. The Johnson & Johnson-partnered asset, ...

A crucial point in Snow’s journey came when she was prescribed a new treatment that required self-injection. Snow, who had ...

Hormone level changes due to growth and development or disease can lead to various eye health issues. Eye changes occur during puberty and menopause, as well as due to low thyroid hormone levels. A ...